Clinical Trials Directory

Trials / Conditions / Relapsed/Refractory B-cell Lymphoma

Relapsed/Refractory B-cell Lymphoma

8 registered clinical trials studyying Relapsed/Refractory B-cell Lymphoma — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
NCT07506668
Affiliated Hospital of Nantong UniversityPhase 1 / Phase 2
Not Yet RecruitingA Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
NCT07316920
YANRU WANGPhase 1
RecruitingEfficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma
NCT07508605
Shenzhen University General HospitalPhase 1 / Phase 2
RecruitingStudy Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
NCT06445517
InSilico Medicine Hong Kong LimitedPhase 1
CompletedFT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
NCT05950334
Fate TherapeuticsPhase 1
RecruitingEfficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
NCT07097207
Shenzhen University General HospitalPhase 1 / Phase 2
UnknownA Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects
NCT03156101
Shenzhen BinDeBio Ltd.Phase 1 / Phase 2
CompletedA Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-C
NCT01766583
The Lymphoma Academic Research OrganisationPhase 1